[8] [9] L-carnitine is generally well-tolerated but there are limited reports suggesting it might affect anticoagulant therapy such as warfarin, which would require closer INR monitoring
It means the evidence base is theoretical, anecdotal, and rooted in pharmacokinetic modeling rather than clinical outcomes data
Glucagon administration also decreases hepatic triacylglycerol synthesis in rats [56] and stimulates hormone-sensitive lipase in human and rat white adipocytes to promote lipolysis and the release of NEFA [57, 58]
This type of fat loss reduces the risk of metabolic syndrome, fatty liver disease, cardiovascular problems, and more
Those can even be telehealth visits
This balanced pharmacology enables researchers to investigate appetite regulation, glucose metabolism, hepatic biology, and energy expenditure within one integrated experimental model